Analysis of the upstream regulators of these candidate genes indicated that the TGFβ (SMAD3) and p53 (CDKN2A) pathways are likely to be involved in mammary tumor susceptibility in response to LDIR (Figure 2G). The gene discussed is CDKN2A; the disease is breast cancer.